Bio-Techne

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bio-Techne and other ETFs, options, and stocks.

About TECH

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases.

CEO

Kim Kelderman

CEOKim Kelderman

Employees

3,100

Employees3,100

Headquarters

Minneapolis, Minnesota

HeadquartersMinneapolis, Minnesota

Founded

1976

Founded1976

Employees

3,100

Employees3,100

TECH Key Statistics

Market cap

9.00B

Market cap9.00B

Price-Earnings ratio

111.88

Price-Earnings ratio111.88

Dividend yield

0.56%

Dividend yield0.56%

Average volume

2.32M

Average volume2.32M

High today

$58.40

High today$58.40

Low today

$56.61

Low today$56.61

Open price

$57.70

Open price$57.70

Volume

2.47M

Volume2.47M

52 Week high

$72.16

52 Week high$72.16

52 Week low

$46.01

52 Week low$46.01

Stock Snapshot

As of today, Bio-Techne(TECH) shares are valued at $57.52. The company's market cap stands at 9B, with a P/E ratio of 111.88 and a dividend yield of 55.6%.

As of 2026-02-21, Bio-Techne(TECH) stock has fluctuated between $56.61 and $58.40. The current price stands at $57.52, placing the stock +1.6% above today's low and -1.5% off the high.

The Bio-Techne(TECH)'s current trading volume is 2.47M, compared to an average daily volume of 2.32M.

During the past year, Bio-Techne(TECH) stock moved between $46.01 at its lowest and $72.16 at its peak.

TECH News

TipRanks 2d

Bio-Techne Insider Move: Director Cashes In on Shares in Notable Stock Sale

New insider activity at Bio-Techne ( (TECH) ) has taken place on February 19, 2026. Bio-Techne director Amy E. Herr has recently sold 1,976 shares of the compa...

Simply Wall St 5d

Will Bio-Techne Turn Ella’s EU Clinical Clearance Into A Precision-Medicine Edge?

Bio-Techne recently announced that its Ella benchtop immunoassay platform has received CE-IVD marking and is now available for clinical use across the European...

Simply Wall St 6d

Assessing Bio-Techne Valuation After Earnings Beat And New 3D Research Tool Launch

Advertisement Why Bio-Techne Is Back on Investor Radar Bio-Techne (TECH) has drawn fresh attention after quarterly results topped Wall Street expectations, su...

Analyst ratings

68%

of 19 ratings

Buy

68.4%

Hold

31.6%

Sell

People also own

Based on the portfolios of people who own TECH. This list is generated using Robinhood data, and it’s not a recommendation.

Broadcom

Microsoft

AMD

Taiwan Semiconductor Manu…

Palo Alto Networks

Alphabet Class A

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.